Dec 3, 2018 | 1:00 PM - 3:00 PM Add to Calendar 03-12-2018 13:00 03-12-2018 15:00 America/Toronto Hypertension & Medication Awareness Presentation DATE: December 3, 2018 TIME: 1:00 pm – 3:00 pm WHERE: ...

Adults who need to track their blood pressure (BP) to find out if they have hypertension prefer to do it at home rather than at a clinic or kiosk or with a 24-hour ambulatory BP monitoring (ABPM), ...

Despite the availability of medications and 25 years of public education, control of hypertension remains a major problem. Nearly 50 percent of America’s 50 million patients with hypertension remain ...

Resistant hypertension remains a tough adversary in the fight against the global rise of cardiovascular disease, but updated ...

Liquidia (LQDA) to feature two live posters sessions and five encore presentations covering its investigational products, YUTREPIA™ (treprostinil) inhalation powder and L606 (liposomal treprostinil) ...

RADNOR, Pa., May 24, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic ...

ZURICH, Switzerland and ORLANDO, Florida, November 6Â /PRNewswire/ -- Prof. Juerg Nussberger, MD, University Hospital of the Canton of Vaud (CHUV), in Lausanne, Switzerland, presents today detailed ...

NEW HOPE, Pa., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Orchestra BioMed™, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company focused on developing transformative therapeutic ...

WASHINGTON--(BUSINESS WIRE)--CorVista Health, Inc., a leading digital health company dedicated to improving cardiovascular disease diagnosis, is pleased to announce the presentation of Machine ...

We report a neonate with IP who presented at birth with persistent pulmonary hypertension of the newborn (PPHN). This early presentation of PPHN, in the neonatal period, has not been described in the ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq: XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics ...